Stock 688553 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sichuan Huiyu Pharmaceutical Co., Ltd.

Equities

688553

CNE100004ZT4

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
14.11 CNY +1.07% Intraday chart for Sichuan Huiyu Pharmaceutical Co., Ltd. -2.69% -6.74%
May. 15 China Grants Drug Registration for Huiyu Pharma's Two Injectables MT
Apr. 26 Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Sichuan Huiyu Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of anti-tumor and injection drugs. The Company’s products are mainly anti-tumor chemical injections, including pemetrexed disodium for injection, docetaxel injection, zoledronic acid injection, irinotecan hydrochloride injection, doxorubicin hydrochloride injection liquid and azacitidine for injection. The Company's products are mainly used in the clinical treatment of various adaptive diseases. The Company distributes its products both in the domestic market and to overseas markets.

Number of employees: 1,669

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical
99.3 %
1,489 99.7 % 921 99.3 % -38.19%
Technical Services
0.6 %
1 0.0 % 6 0.6 % +655.60%
Other
0.1 %
3 0.2 % 1 0.1 % -67.63%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
90.9 %
1,435 96.1 % 843 90.9 % -41.29%
Overseas
9.1 %
58 3.9 % 84 9.1 % +45.79%

Managers

Managers TitleAgeSince
Zhao Ding CEO
 Chief Executive Officer 39 10-10-11
Lan Gao DFI
 Director of Finance/CFO 53 19-10-13
Li Na Ma BRD
 Director/Board Member 48 22-04-30
Yi Dan Zhu IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Li Na Ma BRD
 Director/Board Member 48 22-04-30
Lan Gao DFI
 Director of Finance/CFO 53 19-10-13
Zhao Ding CEO
 Chief Executive Officer 39 10-10-11
Liang Yue BRD
 Director/Board Member 51 10-09-30
Yong Qiang Long BRD
 Director/Board Member 54 20-06-09
Xin Xin Liang BRD
 Director/Board Member 41 20-06-09
Shu Guang Wang BRD
 Director/Board Member 51 19-12-26
Ying Wu BRD
 Director/Board Member 51 21-12-31
Ling Deng CHM
 Chairman 40 17-12-31
Chang Jiang Zhang BRD
 Director/Board Member 53 22-06-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 423,600,000 166,346,440 ( 39.27 %) 0 39.27 %

Shareholders

NameEquities%Valuation
Gan Yi Huang
7.247 %
30,696,852 7.247 % 61 M ¥
Bo Yang
5.002 %
21,190,000 5.002 % 42 M ¥
Xiao Peng Wang
4.022 %
17,037,557 4.022 % 34 M ¥
Yong Ming Cao
4.000 %
16,944,000 4.000 % 34 M ¥
Xun Fan
2.997 %
12,695,629 2.997 % 25 M ¥
Juan Tan
2.884 %
12,215,002 2.884 % 24 M ¥
Shanghai Philip Enterprise Management Center
2.400 %
10,168,467 2.400 % 20 M ¥
Xuzhou Hanyi Enterprise Management Consulting Partnership LP
1.765 %
7,478,498 1.765 % 15 M ¥
Hui Zhen Bao
1.440 %
6,101,134 1.440 % 12 M ¥
Shui Hua Wu
1.440 %
6,100,934 1.440 % 12 M ¥
NameEquities%Valuation
Zhao Ding
84.89 %
114,066,766 84.89 % 226 M ¥
Neijiang Qiyun Enterprise Management Consulting Co. Ltd.
13.69 %
18,397,865 13.69 % 36 M ¥

Company contact information

Sichuan Huiyu Pharmaceutical Co., Ltd.

Building 3 333, Hanyang Road

641000, Neijiang

+

http://www.huiyupharma.com
address Sichuan Huiyu Pharmaceutical Co., Ltd.(688553)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
SICHUAN HUIYU PHARMACEUTICAL CO., LTD. Stock Sichuan Huiyu Pharmaceutical Co., Ltd.
-6.74% 819M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.13% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.56% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.91% 331B
ABBVIE INC. Stock AbbVie Inc.
+6.97% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+8.48% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688553 Stock
  4. Company Sichuan Huiyu Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW